Incyte International Locations
The information contained in company statements should be considered accurate only as of the date of the company statement. We disclaim any obligation to supplement or update the information in these company statements.
Incyte Provides Statement on NIH Initiated Trial of Baricitinib in Combination with Remdesivir for Patients with COVID-19
May 8, 2020
Incyte Provides Updated Statement on Response to COVID-19
March 30, 2020
Incyte Named a Top Five Biopharma Employer by Science Magazine
October 24, 2019
Incyte Supports Wilmington Friends School Strategic Vision and Plan for the Future
October 10, 2019
Incyte Provides Statement on World Health Organization Global Medical Product Alert for Iclusig® (ponatinib)
Updated May 3, 2019
Incyte Provides Statement on Incyte Corporation versus Flexus Biosciences, Inc. Verdict
November 8, 2018
DO YOU WANT TO CONTINUE?